Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 2016

View Archived Issues

New phase I trial explores use of WOKVAC vaccine to prevent breast cancer recurrence

NIH award supports pancreatic cancer study of CivaSheet

Zydus Cadila and Takeda Pharmaceutical partner to tackle chikungunya

NCI awards contract to BioMarker Strategies for predictive test in NSCLC

ResistancePlus MG assay awarded CE-IVD mark

U.S. phase I study of oral OTS-167 to begin in breast cancer

Adgero Biopharmaceuticals obtains financing to support development of REM-001

MabVax Therapeutics gives update on phase I study of MVT-5873

Prozymex patents DPPI inhibitors

Teva and Regeneron enter global collaboration to develop and commercialize fasinumab

Asthma exacerbation model mimics the effects of viral respiratory infections

Amgen's phase III GLAGOV study of evolocumab meets endpoints

Sunovion Pharmaceuticals reports results from pivotal trial of dasotraline in ADHD

BioLineRx begins phase IIa study of BL-8040 plus pembrolizumab in pancreatic cancer

Danish scientists disclose DNA gyrase and topoisomerase IV inhibitors

EMA validates BMS' application to extend Opdivo indications

Long-acting growth hormone CJ-40002 is safe and effective in phase I trial

Amgen describes Nav1.7 channel blockers

Mirna Therapeutics stops phase I trial of MRX-34 following immune-related severe adverse events

BioNTech and Genentech to develop individualized mRNA-based cancer vaccines

Allergan to acquire Tobira Therapeutics

FDA grants fast track designation to Viaskin Milk

Phase III study of vepoloxamer in sickle cell disease does not meet primary efficacy endpoint

Bionomics reports promising phase II results for BNC-210 in generalized anxiety disorder

Kite Pharma signs license with NIH to target KRAS driven cancers

Serum NFL shows promise as a biomarker in RRMS

FDA grants orphan drug designation to CC-122

Follistatin gene therapy receives FDA orphan designation for inclusion body myositis

New biomarkers could help differentiate CIS patients from other forms of multiple sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...